Jane Street Group LLC Invests $366,000 in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

Jane Street Group LLC purchased a new position in shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 9,795 shares of the company’s stock, valued at approximately $366,000.

Separately, Griffin Asset Management Inc. grew its stake in ALPS Medical Breakthroughs ETF by 31.2% in the 3rd quarter. Griffin Asset Management Inc. now owns 30,135 shares of the company’s stock valued at $1,125,000 after buying an additional 7,170 shares in the last quarter.

ALPS Medical Breakthroughs ETF Trading Down 1.9 %

ALPS Medical Breakthroughs ETF stock opened at $32.85 on Thursday. ALPS Medical Breakthroughs ETF has a 1-year low of $31.00 and a 1-year high of $42.73. The firm has a 50 day simple moving average of $36.89 and a 200 day simple moving average of $36.77.

ALPS Medical Breakthroughs ETF Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.